m
Recent Posts
Connect with:
Saturday / November 21.
Homeminews (Page 1077)

The final patient in Opthea’s Phase 2b trial of OPT-302 for wet age-related macular degeneration (AMD) has completed their last clinical visit, paving the

Dr Chameen Samarawickrama, a Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Fellow, has been announced as one of the ABC and University

Gain a significant clinical and business advantage when you attend this dedicated three day event which combines the most credentialed and largest annual optometrists’

Despite The University of Sydney consistently receiving the highest possible ERA score for its research in the discipline of ophthalmology since the inception of

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.